APOTEX INC — Naproxen Importer Profile
Pharmaceutical Importer · #19 buyer for Naproxen · $3.3M import value · 86 shipments · CANADA · DGFT Verified
APOTEX INC is the #19 importer of Naproxen from India with $3.3M in import value and 86 verified shipments. APOTEX INC holds a 1.2% market share in Naproxen imports based in CANADA. The company sources from 1 verified supplier across 71 formulations shipped to 1 country. Overall, APOTEX INC imports 14 pharmaceutical products worth $40.9M across 7 therapeutic categories.
APOTEX INC — Naproxen Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Naproxen to APOTEX INC?
Verified from 86 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| APOTEX RESEARCH PRIVATE LIMITED | $3.3M | 86 | 100.0% |
APOTEX INC sources Naproxen from 1 verified Indian supplier based on 86 customs records. The primary supplier is APOTEX RESEARCH PRIVATE LIMITED accounting for 100.0% of imports.
How Does APOTEX INC Compare to Nearest Naproxen Importers?
Buyers ranked immediately above and below #19 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 12 | GRANULES PHARMACEUTICALS INC | UNITED STATES | $1.9M | 39 | $50.0K |
| 15 | GLENMARK PHARMACEUTICALS INC USA | UNITED STATES | $1.8M | 35 | $50.0K |
| 19 | APOTEX INC ★ | CANADA | $1.7M | 34 | $49.1K |
| 14 | WESTROCK | UNITED STATES | $1.4M | 28 | $50.0K |
| 8 | DR REDDYS LABORATORIES INC | UNITED STATES | $1.1M | 23 | $50.0K |
APOTEX INC ranks #19 among 366 Naproxen importers from India. Average shipment value of $49.1K compared to the market average of $141.4K. The closest competitors by value are GRANULES PHARMACEUTICALS INC and GLENMARK PHARMACEUTICALS INC USA.
Where Does APOTEX INC Import Naproxen To?
Destination countries from 86 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| CANADA | $3.3M | 86 | 100.0% |
APOTEX INC imports Naproxen to 1 country. The primary destination is CANADA receiving 100.0% of shipments worth $3.3M.
What Naproxen Formulations Does APOTEX INC Import?
| Formulation | Value | Shipments |
|---|---|---|
| APO-NAPROXEN 250 MG TAB 100 BTL 41588/77 | $150.0K | 3 |
| APO-NAPROXEN 500 MG TAB 500 BTL, BATCH L | $86.3K | 3 |
| APO-NAPROXEN 250 MG TAB 100 BTL 41588 /771313006286-TZ9638 | $74.9K | 3 |
| APO-NAPROXEN 375 MG TAB 100 BTL 41596/77 | $74.8K | 3 |
| APO-NAPROXEN 375 MG TAB 100 BTL 41596/771313006323-TY4612 | $73.7K | 2 |
| APO-NAPROXEN 250 MG TAB 100 BTL 41588 /771313006286 BATCH LOT NO-VD0737 | $68.9K | 3 |
| APO-NAPROXEN 500 MG TAB 100 BTL 41602 /771313006347 BATCH LOT NO- TY8919 | $50.0K | 1 |
| APO-NAPROXEN 500 MG TAB 100 BTL 41602 /771313006347 BATCH LOT NO- TW9662 | $50.0K | 1 |
| APO-NAPROXEN 500 MG TAB 100 TBL 41602 /771313006347 BATCH LOT NO- TY8918 | $50.0K | 1 |
| APO-NAPROXEN 500 MG TAB 100 BTL 41602 /771313006347 BATCH LOT NO-TX9132 | $50.0K | 1 |
APOTEX INC imports 71 distinct Naproxen formulations from India. The top formulation is APO-NAPROXEN 250 MG TAB 100 BTL 41588/77 with 3 shipments worth $150.0K.
Regulatory Requirements: Importing Naproxen into Canada
What APOTEX INC and other importers must comply with to import Naproxen from India
Regulatory Authority
Health Canada (HC)
Approval Process for Generic Naproxen
Abbreviated New Drug Submission (ANDS) referencing an approved Canadian Reference Product. Comparative bioavailability study required.
Typical timeline: 12–18 months
GMP Requirements
Health Canada GMP (GUI-0001); on-site Drug Establishment Licence (DEL) inspection
Import Licence & Documentation
Drug Establishment Licence (DEL) for importer; Drug Identification Number (DIN) required
Labeling & Packaging
Bilingual (English/French) labeling required; Canadian format per Health Canada guidance
Note: Subject to C.01.014.6 annual review and Good Import Practices requirements.
Regulatory information is provided for general reference based on publicly available HC guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with HC or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Naproxen from India and How Much Does APOTEX INC Import?
India exported $51.8M worth of Naproxen through 3,414 shipments from 192 suppliers to 76 countries, serving 366 buyers globally. APOTEX INC imports $3.3M of this total, accounting for 1.2% of India's Naproxen exports with 86 shipments from CANADA. This is verified from 86 customs shipment records covering 71 distinct formulations.
What Is the Average Order Value for APOTEX INC's Naproxen Imports?
APOTEX INC's average Naproxen order value is $38.9K per consignment, based on 86 shipments totaling $3.3M. APOTEX INC is based in CANADA and ranks #19 among all Naproxen importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Naproxen to APOTEX INC?
APOTEX INC sources Naproxen from 1 verified Indian supplier: APOTEX RESEARCH PRIVATE LIMITED ($3.3M, 100.0%). This is based on 86 customs records.
How Does APOTEX INC Compare to Other Naproxen Importers?
APOTEX INC ranks #19 among 366 Naproxen importers from India with a 1.2% market share. The top 3 importers are GLENMARK PHARMACEUTICALS INC., USA ($11.0M), KRKA D.D., NOVO MESTO ($6.3M), APL SWIFT SERVICES (MALTA) LTD., ($5.2M). APOTEX INC processed 86 shipments from CANADA.
What Other Analgesics & Antipyretics Products Does APOTEX INC Import?
APOTEX INC also imports these analgesics & antipyretics products. Each links to the detailed product page.
About APOTEX INC
APOTEX INC imports 14 products worth $40.9M. Beyond Naproxen, top products include Apixaban, Fluticasone, Atorvastatin, Amino, Acetaminophen. View the complete APOTEX INC profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Naproxen — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Naproxen shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: APOTEX INC matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as APOTEX INC's capped import value divided by total capped export value for Naproxen across all Indian exporters.
- 5.Verified Records: This page is backed by 86 individual customs records matching APOTEX INC importing Naproxen, covering 71 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 76+ countries, 366+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Naproxen Import Data for APOTEX INC
Access order-level details, pricing data, supplier connections, and competitive analysis for APOTEX INC's Naproxen imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
APOTEX INC
Full Company Profile →
14 products · $40.9M total trade · 7 categories
APOTEX INC × Naproxen
Verified from customs records
Company Overview
Top Products by APOTEX INC
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for APOTEX INC.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Naproxen. For current order-level data, contact TransData Nexus.